Q BioMed Inc. Provides Update to Shareholders - June 23, 2023

Q BioMed Inc., a biotech acceleration and commercial stage company, has provided an update to shareholders regarding its financials and OTC listing compliance. The company was unable to file complete audited financials for 2022 due to capital constraints and costs associated with the audit process. As a result, it filed an un-audited annual report for 2022 and Q1 2023 but was downgraded to the '..